Enanta Pharmaceuticals Inc logo

Enanta Pharmaceuticals Inc

NEW
FRA:9EP (USA)  
€ 10.6 -0.20 (-1.85%) Sep 18
At Loss
P/B:
3.55
Market Cap:
€ 309.64M ($ 355.47M)
Enterprise V:
€ 193.00M ($ 221.57M)
Volume:
0
Avg Vol (2M):
2.00
Trade In:

Enanta Pharmaceuticals Inc (FRA:9EP) Dividend

Enanta Pharmaceuticals Inc (FRA:9EP) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -0.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:9EP Dividend

Does Enanta Pharmaceuticals Inc (FRA:9EP) pay a dividend?

Enanta Pharmaceuticals Inc (FRA:9EP) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Enanta Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Enanta Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -0.9% over the past 3 years.

What are dividend-paying alternatives to Enanta Pharmaceuticals Inc?

For dividend-paying alternatives in Enanta Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.